The North America market for facial injectables features a largely oligopolistic vendor landscape, with Allergan Plc - the manufacturer of the famed Botox, accounting for over 62% of the overall market in 2015, observes Transparency Market Research in a recent report. The drug have given Allergen an edge over other players in the market and as the company continues to find novel uses for Botox, it seems unlikely that any generic Botox will enter the market anytime soon.
Although botulinum toxin, the active component in Botox, is used in products such as Xeomin, Dysport, and some new products that are expected to enter the North America market in the near future, the strong brand value of Botox will allow it to rule the market in the future years as well.
Transparency Market Research states that the North America facial injectables market will exhibit a promising 12.0% CAGR over the period between 2016 and 2024, rising from a valuation of US$2.1 bn in 2015 to US$5.8 bn by 2024.
Botulinum Toxin to Remain Most Consumed Active Component in North America Facial Injectables Market
From a geographical standpoint, the facial injectables market is analyzed for the U.S. and Canada. Of these, the U.S. market leads with a sizeable margin and is expected to retain dominance over the forecast period as well, chiefly owing to the high population base and the trend among the U.S. population of generously spending on aesthetic procedures.
Of the key product varieties available in the North America facial injectables market, including botulinum toxin, particle and polymer fillers, collagen, and hyaluronic acid, the segment of botulinum toxin is currently the leading contributor of revenue to the North America facial injectables market. The high popularity of this component for correcting wrinkles, creases, and fine lines on facial skin is the key factor attributable to its high demand in the region.
Increased Expenditure on Aesthetic Procedures to Remain Key to Growth of North America Facial Injectables Market
The increased preference to minimally invasive treatments in dermatological applications is considered the key factor driving the market for facial injectables in North America. Other factors driving the market for facial injectables in the region include the increased focus and expenditure on physical attractiveness and aesthetics and a rising pool of ageing people with high disposable incomes. Factors such as the widening availability of facial injectables in the region as well as the rising number of aesthetic procedure service centers are also driving the market.
Concerns Regarding Possible Allergic Reactions to Hamper Growth Potential
One of the key challenges faced by the North America facial injectables market is the concern regarding the possible allergic reactions that can trigger from the administration of facial injectables owing to their composition, which involves living organisms and related enzymes and chemicals. Moreover, the possibility of occurrence of side-effects such as bruising, bleeding, and edema are also expected to restrict the overall development of the North America facial injectables market in the near future.
This review of the North America facial injectables market is based on a recent market research report published by Transparency Market Research, titled “Facial Injectables Market (Product - Botulinum Toxin, Hyaluronic Acid, Collagen, (Porcine/Bovine-based and Human-based), Particle & Polymer Fillers (PPF) (Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid, and Calcium Hydroxyapatite; Treatment - Facial Pain, Wrinkle Treatment, and Lip Augmentation; End User - Hospitals, Ambulatory Surgical Centers, Cosmetic Centers, Dermatology Clinics, and Physician Clinics) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016-2024.”
For the study, the market has been segmented as follows:
North America Facial Injectables Market, by Product Type
- Botulinum Toxin
- Hyaluronic Acid
- Porcine/ Bovine-Based
- Human Based
- Particle & Polymer Fillers (PPF)
- Polymethylmethacrylate Beads (PMMA microspheres)
- Poly-L-Lactic Acid
- Calcium Hydroxyapatite
North America Facial Injectables Market, by Treatment
- Facial Pain
- Wrinkle Treatment
- Lip Augmentation
North America Facial Injectables Market, by End User
- Ambulatory Surgical Centers
- Cosmetic Centers
- Dermatology Clinics
- Physician Clinics
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453